Altered expression of prolactin receptor-associated signaling proteins in human breast carcinoma

Modern Pathology

Volumn 21, Issue 5, 2008, Pages 565-571

  McHale, Kevin ^a   Tomaszewski, John E ^b   Puthiyaveettil, Ragunath ^b   Livolsi, Virginia A ^b   Clevenger, Charles V ^c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

c myb; Nek3; PIAS3; SIRP; Tissue microarray; Vav2

Indexed keywords

ONCOPROTEIN; PROLACTIN; PROLACTIN RECEPTOR; PROTEIN C MYB; PROTEIN NEK3; PROTEIN PIAS3; PROTEIN SIRP; PROTEIN VAV2; REGULATOR PROTEIN;

ARTICLE; BREAST CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; UPREGULATION;

ANTIGENS, DIFFERENTIATION; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MOLECULAR CHAPERONES; PROTEIN INHIBITORS OF ACTIVATED STAT; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-MYB; PROTO-ONCOGENE PROTEINS C-VAV; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROLACTIN; SIGNAL TRANSDUCTION; TISSUE ARRAY ANALYSIS;

EID: 42549096464     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2008.7     Document Type: Article

References (36)

1. Neville MC, McFadden TB, Forsyth I. Hormonal regulation of mammary differentiation and milk secretion. J Mammary Gland Biol Neoplasia 2002;7:49-66.
2. Miller SL, DeMaria JE, Freier D, et al. Novel assocation of Vav2 and Nek3 modulates signaling through the human prolactin receptor. Mol Endocrinol 2005;19:939-949.
3. Miller SL, Antico G, Raghunath PN, et al. Nek3 kinase regulates prolactin-mediated cytoskeletal reorganization and motility of breast cancer cells. Oncogene 2007;26:4668-4678.
4. Maus MV, Reilly SC, Clevenger CV. Prolactin as a chemoattractant for human breast carcinoma. Endocrinology 1999;140:5447-5450.
5. Clevenger CV, Furth PA, Hankinson SE, et al. The role of prolactin in mammary carcinoma. Endocrine Rev 2003;24:1-27.
6. Stofega MR, Wang H, Ulrich A, et al. Growth hormone regulation of SIRP and SHP-2 tyrosyl phosphorylation and association. J Biol Chem 1998;273:7112-7117.
7. Stofega MR, Argetsinger LS, Wang H, et al. Negative regulation of growth hormone receptor/Jak2 signaling by signal regulatory protein α. J Biol Chem 2001;275:28222-28229.
8. Clevenger CV. Role of Stat family transcription factors in human breast cancer. Am J Pathol 2004;165:1449-1460.
9. Sultan AS, Xie J, LeBaron MJ, et al. Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells. Oncogene 2005;24:746-760.
10. Rycyzyn MA, Clevenger CV. The intranuclear prolactin/cyclophilin B complex as a transcriptional inducer. Proc Natl Acad Sci USA 2002;99:6790-6795.
11. Reynolds C, Montone KT, Powell CM, et al. Expression of Prolactin and its receptor in human breast carcinoma. Endocrinology 1997;138:5555-5560.
12. Kline JB, Roehrs H, Clevenger CV. Functional characterization of the intermediate isoform of the human prolactin receptor. J Biol Chem 1999;274:35461-35468.
13. Graciela AJ, Daniel J, Jolivet G, et al. In vivo study of prolactin (PRL) intracellular signaling during lactogenesis in the rat: JAK/STAT pathway is activated by PRL in the mammary gland but not the liver. Biol Reprod 1997;57:894-900.
14. Nevalainen MT, Xie J, Bubendorf L, et al. Basal activation of transcription factor Stat5 in nonpregnant mouse and human breast epithelium. Mol Endocrinol 2002;16:1108-1124.
15. Xie J, LeBaron MJ, Nevalainen MT, et al. Role of tyrosine kinase Jak2 in prolactin-induced differentiation and growth of mammary epithelial cells. J Biol Chem 2002;277:14020-14030.
16. Bustelo XR. Regulatory and signaling properties of the Vav family. Mol Cell Biol 2000;20:1461-1477.
17. Palmby TR, Abe K, Karnoub AE, et al. Vav transformation requires activation of multiple GTPases and regulation of gene expression. Mol Cancer Res 2004;2:702-711.
18. Schuebel KE, Movilla N, Rosa JL, et al. Phosphorylation-dependent and constitutive activation of Rho proteins by wild-type and oncogenic Vav-2. EMBO J 1998;17:6608-6621.
19. Abe K, Rossman KL, Liu B, et al. Vav2 is an activator of Cdc42, Rac1, and RhoA. J Biol Chem 2000;275:10141-10149.
20. Hall A. Rho GTPases and the actin cytoskeleton. Science 1998;279:509-514.
21. Calo V, Migliavacca M, Bazan V, et al. Stat proteins: from normal control of cellular events to tumorigenesis. J Cell Physiol 2003;197:157-168.
22. Kapoor GS, Kapitonov D, O'Rourke DM. Transcriptional regulation of signal regulatory protein α1 inhibitory receptors by epidermal growth factor receptor signaling. Cancer Res 2004;64:6444-6452.
23. Oshima K, Machida K, Ichigotani Y, et al. SHPS-1: a budding molecule against cancer dissemination. Cancer Res 2002;62:3929-3933.
24. Darnell JE. Transcription factors as targets for chemotherapy. Nat Rev Cancer 2002;2:740-749.
25. Ren S, Cai HR, Li M, et al. Loss of Stat5a delays mammary cancer progression in a mouse model. Oncogene 2002;21:4335-4339.
26. Bromberg JF, Wreszczynska MH, Devgan G, et al. Stat3 as an oncogene. Cell 1999;98:295-303.
27. Oh I, Reddy EP. The myb gene family in cell, growth, differentiation and apoptosis. Oncogene 1999;18:3017-3033.
28. Kauraniemi P, Hednfalk I, Persson K, et al. Myb oncogene amplification in hereditary BRCA1 breast cancer. Cancer Res 2000;60:5323-5328.
29. Rogers RS, Horvath CM, Matunis MJ. SUMO modification of STAT1 and its role in PIAS3-mediated inhibition of gene activation. J Biol Chem 2003;278:30091-30097.
30. Chung CD, Liao J, Liu B, et al. Specific inhibition of Stat3 signal transduction by PIAS3. Science 1997;278:1803-1805.
31. Liu B, Liao J, Rao X, et al. Inhibition of Stat1-mediated gene activation by PIAS1. Proc Natl Acad Sci USA 1998;95:10626-10631.
32. 2 by sumoylation of p73. Mol Cell Biol 2004;24:10593-10610.
33. Shuai K. Modulation of STAT signaling by STAT-interacting proteins. Oncogene 2000;19:2638-2644.
34. Shuai K, Liu B. Regulation of JAK-STAT signalling in the immune system. Nat Rev Immunol 2003;3:900-911.
35. Wang L, Banerjee S. Differential PIAS3 expression in human malignancy. Oncol Rep 2004;11:1319-1324.
36. Li Y, Clevenger CV, Minkovsky N, et al. Stabilization of prolactin receptor in breast cancer cells. Oncogene 2006;25:1896-1902.